CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
COMPLIANCE UNDER REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015.20-11-2020
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
COMPLIANCE UNDER REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015.CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
COMPLIANCE UNDER REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015.CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herewith enclose a copy of newspaper advertisement published in the Financial Express(English) and Maalai Malar (Tamil) dated November 07,2020 with respect to Un-audited Financial Results for quarter/half year ended September 30,2020 approved by the Board of Directors of the Company at their meeting held on November 05,2020.Earnings Call for Q2FY21 of Caplin Point Laboratories
Conference Call with Caplin Point Laboratories Ltd. Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript. Management in attendance: Mr. C.C. Paarthipan Chairman Mr. Vivek Partheeban Chief Operating Officer Dr Sridhar Ganesan Managing Director Mr. D. Muralidharan Chief Financial Officer Mr. M. Sathyanarayanan Deputy Chief Financial Officer Mr. Vinod Kumar Company SecretaryCAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
COMPLIANCE UNDER REGULATION 39(3) OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015CAPLIN POINT LABORATORIES LTD. - 524742 - Un-Audited Financial Results For The Quarter/Half Year Ended September 30,2020
Un-audited Financial Results for the quarter/half year ended September 30,2020CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,we herewith enclose the copy of newspaper advertisement published in Financial express(English) and Maalai Malar ( Tamil) on October 30,2020 in view of the Board Meeting scheduled to be held on Thursday, November 05,2020, to consider, approve and take on record the Un-audited Financial Results for the quarter/half year ended September 30,2020CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Management of the Company will host a conference call on Friday, November 06,2020 at 11:00 AM on Un-audited Financial Results for the quarter/half year ended September 30,2020 and future outlookCAPLIN POINT LABORATORIES LTD. - 524742 - Board Meeting Intimation for Considering Un-Audited Financial Results For Quarter/Half Year Ended September 30,2020
CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2020 ,inter alia, to consider and approve Un-audited Financial Results for quarter/half year ended September 30,2020CAPLIN POINT LABORATORIES LTD. - 524742 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1010 Name of the Signatory :- Vinod Kumar SDesignation :- Company Secretary and Compliance Officer